TNFRSF6B and cancer: DcR3 overexpression has been reported in many cancers including lung and colon cancers, Epstein–Barr virus (EBV) or human T-cell lymphotropic virus-1 (HTLV-1)-associated lymphomas, gliomas, and pancreatic adenocarcinomas as well as bone and soft tissue sarcomas (105).